Mano Y, Koide K, Sukegawa H, Kodaira M, Ohki T. Successful resolu- tion of a left ventricular thrombus with apixaban treatment following acute myocardial infarction. Heart Vessels. 2016;31:118 123. doi: 547. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct car- diomyopathy. Heart. 2001;86:666 671. doi: 10.1136/heart.86.6.666 548. Ross SB, Jones K, Blanch B, Puranik R, McGeechan K, Barratt A, Semsarian C. A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults. Eur Heart J. 2020;41:1428 549. Ritter M, Oechslin E, S tsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997;72:26 550. Di Tullio MR, Qian M, Thompson JL, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, et al; WARCEF Investigators. Left ventricular ejection fraction and risk of stroke and cardiac events in heart failure: data from the Warfarin Versus Aspirin in Reduced Ejection Fraction trial. Stroke. 2016;47:2031 2037. doi: 551. Meurin P, Tabet JY, Renaud N, Weber H, Grosdemouge A, Bourmayan C, Driss AB. Treatment of left ventricular thrombi with a low molecular weight heparin. Int J Cardiol. 2005;98:319 323. doi: 10.1016/j.ijcard. 552. Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, J ni P, Mattle HP, et al. Device closure of patent foramen ovale after stroke: pooled analysis of completed ran- domized trials. J Am Coll Cardiol. 2016;67:907 917. doi: 10.1016/j. 553. Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol. 2018;71:2335 2342. 554. 